Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Agricultural Regulatory Specialist
Surya Prabha is a seasoned compliance and regulatory affairs leader with over a decade of experience advising life sciences and technology organizations on complex regulatory, legal, and operational frameworks. She brings deep expertise in global regulatory compliance, contract lifecycle management, and enterprise risk mitigation, with a strong focus on the pharmaceutical, biotechnology, and medical device sectors.
Her experience spans regulatory strategy and execution across major jurisdictions, including the U.S. FDA, Health Canada, and international notified bodies. She has extensive hands-on involvement in regulatory submissions, CMC documentation, quality systems, and inspection readiness, including support for IND, NDA, and ANDA filings, master file management, and cGMP compliance. Surya has played a key role in guiding organizations throughout the product lifecycle—from development to post-market regulatory obligations.
In addition to her regulatory expertise, Surya is a recognized leader in compliance program development and legal operations. She has designed and implemented enterprise-wide compliance frameworks, including third-party risk management systems, anti-corruption programs, and internal reporting mechanisms. Her work includes developing policy infrastructure and contract governance models, and leading negotiations on agreements such as CDAs, MSAs, CTAs, and consulting contracts.
Surya is also highly skilled in optimizing legal and compliance operations through technology-enabled solutions. She has extensive experience with platforms such as SAP, Oracle ERP, Conga, Apttus, Agiloft CLM, and Power BI. She has led digital transformation initiatives to improve contract management, data visibility, and compliance tracking.
Earlier in her career, she held key roles in audit, compliance, and corporate counsel functions, conducting risk assessments, internal audits, and policy enforcement across global organizations. Her multidisciplinary background allows her to effectively bridge legal, regulatory, and business perspectives to deliver practical, scalable solutions.
She holds a Master of Science in Law (Life Sciences) from Suffolk University Law School (Boston, Massachusetts) and a Juris Doctor from India. She is also CITI Program certified in research involving human subjects, reflecting her commitment to ethical and compliant research practices.
With a strategic mindset and detail-oriented approach, Surya partners with organizations to strengthen compliance infrastructures, navigate regulatory complexity, and drive sustainable growth in highly regulated environments.
Agricultural Regulatory Specialist
Ancelin Ashmita Pal is the Principal Consultant for Agricultural Products at Rigor Consulting Group LLC. With over a decade of hands-on experience at the California Department of Food and Agriculture (CDFA), she brings unparalleled expertise in agricultural regulatory compliance, commodity inspection, and quality assurance program development. Ancelin is a USDA-certified inspection specialist with deep knowledge of specialty crops including almonds, pistachios, walnuts, and other California commodities. She has developed and implemented inspection programs, guided agricultural businesses through complex regulatory frameworks, and helped farmers and agribusinesses achieve and maintain compliance with state and federal standards. Her practical, field-tested approach ensures that clients receive actionable guidance grounded in real regulatory experience.
Dr. Joseph Nkurunziza is the Co-Founder and Managing Director of Rigor Consulting Group LLC, a strategic Pharmaceutical economist with over a decade of experience across academia, research, and industry. His rare trifecta of credentials — a PhD in Pharmaceutical Economics and Policy, an MS in Law (Life Sciences), and an MBA in Healthcare Management — uniquely positions him to deliver holistic, evidence-based solutions that bridge scientific rigor with business and legal acumen.
Dr. Nkurunziza works as the principal consultant with pharma and biotech clients across a broad portfolio of life sciences engagements, helping pharma and biotech companies navigate HTA, HEOR, budget impact, and economic modeling that inform pricing and reimbursement decisions across multiple therapeutic areas. His expertise spans cost-effectiveness analysis, budget impact modeling, value-based pricing, and HTA submissions — with particular depth in oncology and infectious disease programs — aligned with ICER, ISPOR, and international HTA standards.
His doctoral research at Massachusetts College of Pharmacy and Health Sciences University focused on the economic analysis of sequential tyrosine kinase inhibitors in the treatment of Chronic Myeloid Leukemia in the United States. He also conducted pharmaceutical economics research at the institution’s International Center for Pharmaceutical Economics and Policy, co-authoring peer-reviewed work on authorized generics in the United States.
A trusted advisor to pharmaceutical companies, healthcare organizations, and government agencies, Dr. Nkurunziza helps clients navigate the evolving landscape of health policy and market access with deep expertise in pharmacoeconomic modeling, regulatory intelligence, and commercial strategy. He is an active member of both ISPOR and the Boston Bar Association.
Certifications: Human Subjects Research (HSR) | SAS Base Programming | SAS Advanced Programming | SAS Clinical Trials | Health Technology Assessment